Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
213411-83-7Cc1oc(-c2ccccc2)nc1CCOc1ccc(CC2SC(=O)NC2=O)c2sccc12HAAXAFNSRADSMK-UHFFFAOYSA-NEdaglitazone is an agent belonging to the glitazone class of antidiabetic agents with antihyperglycemic activity. Edaglitazone also appears to lower triglyceride and free fatty acid levels.
BeschreibungEdaglitazone is an agonist of peroxisome proliferator-activated receptor γ (PPARγ). It activates PPARγ in a reporter assay using CV-1 cells expressing murine PPARγ2 when used at concentrations ranging from 0.1 to 1 μM. Edaglitazone (1, 5, and 25 μM) increases [3H]2-deoxyglucose transport in the presence and absence of insulin and increases glycogen synthesis in the presence of insulin in soleus muscle strips isolated from obese rats.
VerwendenTreatment of Type 2 diabetes.
213411-83-7、892128-35-7、892128-36-8DTXSID00870240CHEMBL3990804